Rutgers Cancer Institute and RWJBarnabas Health to Present Data at the 2023 ASCO Gastrointestinal (GI) Cancers Symposium

Kohler Research Program - Publications

  • Kohler RE, Wagner R, Careaga K, Btoush R, Greene K, Kantor L. Mothers' perceptions and attitudes about HPV vaccination initiation among 9- and 10-year-olds. Human Vaccines & Immunotherapeutics 2023. 19(3):2270842
  • Kohler RE, Hemler J, Wagner R, Sullivan B, Macenat M, Tagai EK, Miller SM, Wen KY, Ayers C, Einstein MH, Hudson SV. Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy – “the land of the unknown” Patient Education and Counseling 2023.

Profile of Dr. Kohler

Dr. KohlerDr. Racquel “Kelly” Kohler received her MSPH in Health Policy and Management and her PhD in Health Services Research at the University of North Carolina at Chapel Hill. She lived and worked in Malawi as a Fogarty fellow to conduct her mixed methods dissertation study on advanced breast cancer diagnosis. Dr. Kohler completed her postdoctoral fellowship in Cancer Prevention at the Harvard T.H. Chan School of Public Health and Dana-Farber Cancer Institute.

Gulhati Pancreatic Cancer Release 012023

Triple Immunotherapy Combination Potential Treatment for Pancreatic Cancer

Researchers from Rutgers Cancer Institute, with RWJBarnabas Health and in collaboration with investigators from MD Anderson, discovered a novel triple immunotherapy combination, targeting checkpoints on both T cells and myeloid suppressor cells, that dramatically improved anti-tumor responses by reprogramming the tumor microenvironment in preclinical models of PDAC.

Subscribe to